Synlogic, Inc. SYBX
SYBX
Synlogic, Inc. LIXT
Lixte Biotechnology Holdings, Inc. ALLR
Allarity Therapeutics, Inc. LEXX
Lexaria Bioscience Corp. CUPR
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares CING
Cingulate Inc. CRIS
Curis, Inc. ENTO
Entero Therapeutics, Inc. KAPA
Kairos Pharma, Ltd. BCTX
BriaCell Therapeutics Corp.
Synlogic, Inc. LIXT
Lixte Biotechnology Holdings, Inc. ALLR
Allarity Therapeutics, Inc. LEXX
Lexaria Bioscience Corp. CUPR
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares CING
Cingulate Inc. CRIS
Curis, Inc. ENTO
Entero Therapeutics, Inc. KAPA
Kairos Pharma, Ltd. BCTX
BriaCell Therapeutics Corp.
Performance
| Periode | SYBX | LIXT | ALLR | LEXX | CUPR | CING | CRIS | ENTO | KAPA | BCTX |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -2.50 % | 419.90 % | 6.06 % | -35.93 % | -92.34 % | -1.70 % | -51.61 % | 89.21 % | 17.62 % | -72.39 % |
| YTD | -17.61 % | 82.43 % | -5.41 % | -75.65 % | -88.47 % | -20.78 % | -75.24 % | 35.57 % | -51.49 % | -90.70 % |
| 1Y | -17.02 % | 104.55 % | -2.78 % | -76.37 % | -88.47 % | -16.18 % | -66.56 % | 39.15 % | -55.56 % | -89.93 % |
| 3Y | -89.38 % | -17.35 % | -100.00 % | -76.27 % | -88.47 % | -98.13 % | -88.83 % | -98.74 % | -71.45 % | -98.74 % |
| 5Y | -96.42 % | -88.33 % | -100.00 % | -87.50 % | -88.47 % | -99.62 % | -99.33 % | -100.00 % | -71.45 % | -98.68 % |
| 10Y | -97.19 % | -77.50 % | -100.00 % | -87.50 % | -88.47 % | -99.62 % | -99.63 % | -100.00 % | -71.45 % | 5 226.92 % |
| From the beginning | -64.22 % | -99.85 % | -100.00 % | -87.50 % | -88.47 % | -99.62 % | -99.96 % | -100.00 % | -71.45 % | 1 644.55 % |